Settlement talks are currently underway between manufacturers of transvaginal mesh and women who say they suffered serious complications from the defectively designed products.
Attorneys for Boston Scientific, Coloplast, Cook Medical, and C.R. Bard entered into discussions to resolve the tens of thousands of lawsuits waged against them. The only manufacturer that did not join the discussion was Ethicon, a subsidiary of Johnson & Johnson.
There are more than 30,000 lawsuits against the five companies that are engaged in settlement talks. However, that number is expected to grow to upwards of 50,000 as more plaintiffs join in the settlement proceedings.
Transvaginal mesh, also known as bladder sling, is used to treat common pelvic floor disorders such as pelvic organ prolapse and stress urinary incontinence. The Food and Drug Administration (FDA) has warned twice in recent years that serious side effects with the mesh are not uncommon. Complications include erosion of the device into vaginal tissue resulting in pain, incontinence, infections and hemorrhaging. Many women have required multiple surgeries to remove the mesh. Some cases have been fatal.
Several manufacturers have already taken their cases to court and were ordered to pay millions to the plaintiffs who were injured. C.R. Bard lost two trials – the company was ordered to pay $5.5 million to the first plaintiff and $2 million to the second. Johnson & Johnson/Ethicon was ordered to pay $11 million to a woman who had to undergo 18 surgeries related to mesh complications.
Women who have had transvaginal mesh implanted and suffered from problems are encouraged to consult with an attorney as time is running out for them to file lawsuits against the manufacturers.
Source: Drug Watch